WO2003020975A3 - OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA - Google Patents

OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA Download PDF

Info

Publication number
WO2003020975A3
WO2003020975A3 PCT/GB2002/003948 GB0203948W WO03020975A3 WO 2003020975 A3 WO2003020975 A3 WO 2003020975A3 GB 0203948 W GB0203948 W GB 0203948W WO 03020975 A3 WO03020975 A3 WO 03020975A3
Authority
WO
WIPO (PCT)
Prior art keywords
human papillomavirus
mrna
oligonucleotides
detection
probes
Prior art date
Application number
PCT/GB2002/003948
Other languages
French (fr)
Other versions
WO2003020975A2 (en
Inventor
Frank Karlsen
Original Assignee
Norchip As
Frank Karlsen
Allard Susan Joyce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norchip As, Frank Karlsen, Allard Susan Joyce filed Critical Norchip As
Priority to AU2002329384A priority Critical patent/AU2002329384A1/en
Publication of WO2003020975A2 publication Critical patent/WO2003020975A2/en
Publication of WO2003020975A3 publication Critical patent/WO2003020975A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Oligonucleotide primers and probes for use in detecting the presence of mRNA transcripts from the L1 gene of human papillomavirus in clinical samples.
PCT/GB2002/003948 2001-08-31 2002-08-30 OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA WO2003020975A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002329384A AU2002329384A1 (en) 2001-08-31 2002-08-30 Oligonucleotides for use in detection of human papillomavirus l1 mrna

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0121166A GB0121166D0 (en) 2001-08-31 2001-08-31 Detection of human papillomavirus L1 mRNA
GB0121166.3 2001-08-31

Publications (2)

Publication Number Publication Date
WO2003020975A2 WO2003020975A2 (en) 2003-03-13
WO2003020975A3 true WO2003020975A3 (en) 2003-10-16

Family

ID=9921333

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/003948 WO2003020975A2 (en) 2001-08-31 2002-08-30 OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA

Country Status (3)

Country Link
AU (1) AU2002329384A1 (en)
GB (1) GB0121166D0 (en)
WO (1) WO2003020975A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100801454B1 (en) * 2002-10-24 2008-02-11 (주)지노믹트리 DNA Chip and Preparation thereof
JP2006521104A (en) * 2003-03-25 2006-09-21 ブーヒナー・エルヴィン Method for early diagnosis of carcinoma and test kit for performing the same
WO2005100598A1 (en) 2004-04-19 2005-10-27 Genomictree Inc. Method for preparing a dna chip and use thereof
EP2172563A1 (en) * 2008-09-24 2010-04-07 bioMérieux S.A. Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010675A1 (en) * 1990-01-19 1991-07-25 Stichting Researchfonds Pathologie Primers and process for detecting human papillomavirus genotypes by pcr
WO1995022626A1 (en) * 1994-02-21 1995-08-24 Stichting Researchfonds Pathologie Human papilloma virus detection in a nucleic acid amplification process using general primers
US5705627A (en) * 1988-09-09 1998-01-06 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction using specific L1, and E6 probes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705627A (en) * 1988-09-09 1998-01-06 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction using specific L1, and E6 probes
WO1991010675A1 (en) * 1990-01-19 1991-07-25 Stichting Researchfonds Pathologie Primers and process for detecting human papillomavirus genotypes by pcr
WO1995022626A1 (en) * 1994-02-21 1995-08-24 Stichting Researchfonds Pathologie Human papilloma virus detection in a nucleic acid amplification process using general primers

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KRAUS I ET AL: "Real-time NASBA as a clinically relevant method for detection of human papillomavirus mRNA: A study of 190 Norwegian cervical biopsies.", INTERNATIONAL JOURNAL OF CANCER SUPPLEMENT, no. 13, 2002, 18th UICC International Cancer Congress;Oslo, Norway; June 30-July 05, 2002, pages 110 - 111, XP001153488, ISSN: 0898-6924 *
MOLDEN T ET AL: "Multiplex real time NASBA, a new method for identification of active oncogenic human papilloma virus (HPV) mRNA.", INTERNATIONAL JOURNAL OF CANCER SUPPLEMENT, no. 13, 2002, 18th UICC International Cancer Congress;Oslo, Norway; June 30-July 05, 2002, pages 319, XP001153489, ISSN: 0898-6924 *
SMITS HENK L ET AL: "Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts.", JOURNAL OF VIROLOGICAL METHODS, vol. 54, no. 1, 1995, pages 75 - 81, XP002248995, ISSN: 0166-0934 *
SNIJDERS P J F ET AL: "THE USE OF GENERAL PRIMERS IN THE POLYMERASE CHAIN REACTION PERMITS THE DETECTION OF A BROAD SPECTRUM OF HUMAN PAPILLOMAVIRUS GENOTYPES", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 71, 1990, pages 173 - 181, XP000255765, ISSN: 0022-1317 *

Also Published As

Publication number Publication date
AU2002329384A1 (en) 2003-03-18
GB0121166D0 (en) 2001-10-24
WO2003020975A2 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
EP2272988A3 (en) Method for detecting human papillomavirus mRNA
AU2002361946A1 (en) Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof
AU2002366046A1 (en) Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes
CA2296144A1 (en) Oligonucleotide primers for efficient detection of hepatitis c virus (hcv) and methods of use thereof
PT1687609E (en) Fluorescent probes for dna detection by hybridization with improved sensitivity and low background
AU2002239679A1 (en) Rolling circle amplification detection of rna and dna
WO2004013357A3 (en) Nucleotide sequences specific to francisella tularensis and methods for the detection of francisella tularensis
AU2003233451A1 (en) Targets, methods, and reagents for diagnosis and treatment of schizophrenia
WO2006063065A3 (en) Detection of nucleic acids from multiple types of human papillomaviruses
EP1802756A4 (en) Probe of human papillomavirus and dna chip comprising the same
AU2001290579A1 (en) Methods for detecting papillomavirus dna in blood plasma and serum
AU2002259117A1 (en) Systems and methods for detection of analytes in biological fluids
HUP0200981A3 (en) Pcr reactions with hybridizing probes using primers with broad genotype-specificity for detection of human papilloma-viruses and typing amplificates by using specifically hybridizing oligonucleotides
WO2006037462A3 (en) Cancer markers
AU2003226208A1 (en) Polynucleotide primers and probes for rapid detection of group b streptococcus (gbs)
IL172652A0 (en) Method for the detection of gene transcripts in blood and uses thereof
WO2003020975A3 (en) OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA
AU2002345854A1 (en) Methods for detecting and monitoring cox-2 rna in plasma and serum
WO2002008460A3 (en) Methods for detection of human papillomavirus mrna
WO2003020976A3 (en) Oligonucleotides for use in detection of human papillomavirus e7 mrna
EP1573041A3 (en) Detection and typing of human papillomavirus using pna probes
AU2003279873A1 (en) Detection and typing of human papillomavirus using pna probes
WO2007001310A3 (en) Methods and compositions for detecting rhinoviruses
EP1391519A4 (en) Nonspecific hybridization inhibitors, clinical examination reagents and clinical examination method
WO2002036604A3 (en) Diagnosis of diseases associated with the human c-mos gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP